Thermo Fisher touts product launches at AACC 2021

By staff writers

September 29, 2021 -- Thermo Fisher Scientific is highlighting a variety of new products the company is launching at this week's American Association for Clinical Chemistry (AACC) meeting, including new test kits for COVID-19 and for lupus.

For COVID-19, there are two polymerase chain reaction (PCR) tests: the Applied Biosystems TaqPath COVID-19 Fast PCR Combo Kit 2.0 and the Applied Biosystems TaqPath COVID-19 RNase P Combo Kit 2.0. The tests target eight genes across three regions of SARS-CoV-2.

What's more, Thermo Fisher announced that its existing Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel can now detect the Mu variant of the SARS-CoV-2 virus. The company has also launched the Thermo Scientific AcroMetrix SARS-CoV-2 Control, which is targeted at monitoring extraction, amplification, and detection steps for SARS-CoV-2 assays.

Apart from COVID-19 testing, Thermo Fisher is launching the EliA SmDP-S test to aid in the diagnosis of systemic lupus erythematosus (SLE). The test recently received U.S. Food and Drug Administration (FDA) clearance.

In the substance abuse screening field, the company launched DRI Fentanyl II, an assay for fentanyl detection that has FDA clearance, and the firm partnered with Mindray to offer two new analyzers, Mindray BS480 and Mindray BA800M. The latter analyzers can run up to 800 tests per hour.

In other news, Thermo Fisher said it was donating equipment for the COVID-19 Immunity Study sponsored by the AACC. The donation will enable onsite serology testing that will analyze immune responses to SARS-CoV-2 among participants who have received the vaccine.

Thermo Fisher gets FDA approval for lung cancer test
Thermo Fisher Scientific's Oncomine Dx Target Test for use as a companion diagnostic in patients with non-small cell lung cancer recently received approval...
Thermo Fisher, AstraZeneca to develop NGS companion diagnostics
Thermo Fisher Scientific and AstraZeneca plan to co-develop companion diagnostics based on next-generation sequencing (NGS) to support targeted therapies.
FDA clears Thermo Fisher's new blood test for lupus
The U.S. Food and Drug Administration (FDA) cleared Thermo Fisher Scientific's blood test for diagnosing systemic lupus erythematosus, the most common...
Thermo Fisher launches new electron microscope
Thermo Fisher Scientific has unveiled its new Helios 5 PXL Wafer DualBeam, a plasma-focused ion beam scanning electron microscope. The microscope can...
FDA clears Thermo Fisher multi-infection PCR test
The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to Thermo Fisher Scientific for the company's multi-infection TaqPath...

Copyright © 2021

Last Updated ls 9/28/2021 5:02:27 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current